POSTER SESSION V
Wednesday, March 21, 2012   —  9:30 AM - 12:00 Noon
CC Exhibit Hall B3 & C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


GYNECOLOGIC PATHOLOGY & OBSTETRICS



Poster#Title and AuthorsItinerary
Planner
128 Negative Loop Electrosurgical Cone Biopsy Following a Biopsy Diagnosis of High-Grade Squamous Intraepithelial Lesion: Frequency and Clinical Significance (1263)
BL Witt, RE Factor, EA Jarboe, LJ Layfield - University of Utah School of Medicine, Salt Lake City, UT; ARUP Laboratories, Salt Lake City, UT 		Add
129 Negative for Dysplasia in Loop Electrosurgical Excision Procedure (LEEP) and Cold Knife Cone Biopsy: Review of 380 Cases (1258)
NT Vo, S Zhang - Louisiana State University Health Sciences Center, Shreveport, LA 		Add
130 Levels and P16 Are Valuable Adjuncts in the Evaluation of Cervical Cone or Loop Electrosurgical Excision Procedure (LEEP) Specimens Initially Considered Negative for Dysplasia (1101)
AB Carrigg, N Weidner, G Lin, M Peterson, F Hasteh - University of California San Diego Medical Center, San Diego, CA 		Add
131 Radial Margins Status Impact in Squamous Cervical Cancer Recurrence: A Considerable Prognostic Factor (1100)
R Canas Marques, P Simoes, I Santana, A Gomes, AF Jorge, A Felix - Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal; Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal 		Add
132 Survivin Expression in Cervix Carcinoma Correlates with Residual Disease after Neoadjuvant Radio-Chemotherapy (1275)
GF Zannoni, VG Vellone, ED Rossi, G Fadda, G Chiarello, G Scambia, G Rindi - Catholic University, Rome, Italy 		Add
133 Fluorescence In Situ Hybridization (FISH) for Detection of MAML2 Rearrangement in Patients with Adenosquamous Carcinoma of Uterine Cervix (1237)
G Rasty, S Kamel-Ried - University Health Network and LMP, University of Toronto, Toronto, ON, Canada 		Add
134 Cervical Carcinomas with Neuroendocrine Differentiation: A Report of 29 Cases with Immunohistochemical Analysis and Molecular Genetic Evidence of Common Clonal Origin with Coexisting Squamous and Adenocarcinomas (1123)
RE Emerson, H Michael, M Wang, LM Roth, L Cheng - Indiana University School of Medicine, Indianapolis, IN 		Add
135 Mesonephric Adenocarcinoma of the Uterus and Cervix – A Clinicopathologic Study of 10 Cases (1167)
C Jimenez, M Nucci, C Zaloudek - UCSF, San Francisco, CA; Brigham and Women´s Hospital, Boston, MA 		Add
136 Differences in Mismatch Repair Protein Expression of Cervical Adenocarcinoma and Carcinoma of the Lower Uterine Segment (1156)
B Helmchen, R Brand, M Kurrer, P Komminoth, P Sinn - Stadtspital Triemli, Zürich, Switzerland; University of Heidelberg, Heidelberg, Germany; Enge Institute of Pathology, Zurich, Switzerland 		Add
137 Lynch Syndrome Screening Tests in Uterine Cancer Patients >50 Years Depends on Clinical and Tumor Morphology Criteria: Evidence Against Universal Testing (1099)
SM Calkins, AN Karnezis, PG Conrad, L-M Chen, JT Rabban - UCSF, San Francisco, CA 		Add
138 Conventional Screening Criteria May Miss a High Proportion of Lynch Syndrome Patients with Endometrial Carcinoma Due to PMS2 Loss (1118)
B Djordjevic, RR Broaddus - University of Ottawa, Ottawa, ON, Canada; M.D. Anderson Cancer Center, Houston, TX 		Add
139 Prevalence of Lynch Syndrome among Unselected Endometrial Cancer Patients (1084)
C Alenda, C Egoavil, JL Soto, A Castillejo, VM Barbera, MJ Roman, AB Sanchez, JA Lopez, O Pinero, C Guarinos, L Perez-Carbonell, M Rodriguez, G Peiro, E Rojas, MJ Gonzalez, S Ciguenza, JC Martinez-Escoriza, R Jover, FI Aranda, A Paya - University Hospital, Alicante, Spain; University Hospital, Elche, Spain 		Add
140 Histologic Evaluation of Prophylactic Hysterectomies in Women with Lynch Syndrome (1173)
Y Karamurzin, R Soslow, K Garg - Memorial Sloan-Kettering Cancer Center, New York, NY 		Add
141 Body Mass Index Correlates with Mismatch Repair Protein Expression in Endometrial Carcinomas (1232)
CM Perrino, AS Joehlin-Price, AC Schmitt, DE Cohn, JA Stephens, AA Suarez - The Ohio State University, Columbus, OH 		Add
142 mTOR and STMN1 Expression Is Associated with Type I Endometrial Carcinoma (1104)
JSY Chan, LH Ellenson - NYP-Weill Cornell Medical Center, New York City, NY 		Add
143 CTNNB1 Mutation, β-Catenin and E-Cadherin Expression and the Relationship with Clinical and Histopathological Prognostic Factors in Endometrial Adenocarcinomas and Hyperplasias (1221)
N Ozeren, D Gumurdulu, B Guzel, H Zeren, M Ergin, MA Vardar, A Altintas - Cukurova University, Faculty of Medicine, Adana, Turkey 		Add
144 Downregulation of CYP27A1 Expression and Activity in Human Endometrial Carcinoma Implicates an Abnormal Bioactivation of Vitamin D in Advanced Endometrial Carcinogenesis (1222)
J Pallares, L Bergada, M Santacana, X Dolcet, J Valls, A Dusso, X Matias-Guiu - Hospital Universitari Arnau de Vilanova , University of Lleida, Irblleida, Lleida, Spain 		Add
145 B-RAF V600E Mutations in Endometrial Adenocarcinoma (1153)
S Hang, V Breese, M He, C Zhang, J Xiong, CL Jackson - Warren Alpert Medical School of Brown University, Providence, RI; Rhode Island Hospital, Providence, RI; Women & Infants Hospital of Rhode Island, Providence, RI 		Add
146 Loss of ARID1A Expression Correlates with Stages of Tumor Progression in Uterine Endometrioid Carcinoma (1199)
T-L Mao, L Ardighieri, R Li, M-C Lin, A Ayhan, RJ Kurman, I-M Shih - Johns Hopkins Medical Institutions, Baltimore; National Taiwan University College of Medicine, Taipei, Taiwan; Seirei Mikatahara General Hospital, Hamamatsu, Japan 		Add
147 ARID1A Gene Expression in High-Grade Endometrial Carcinomas (1086)
G Allo, H Mackay, M Rouzbahman, P Shaw, M Bernardini, BA Clarke - University of Toronto, University Health Network, Toronto, ON, Canada 		Add
148 Interobserver Agreement in the Diagnosis of Ovarian Carcinoma Types: Impact of Sub-Specialization (1228)
C Patel, B Harmon, R Soslow, K Garg, D DeLair, S Hwang, J Liu, S Zee, K Shroyer, S Burke, C Tornos - Stony Brook University Medical Center, Stony Brook, NY; Memorial Sloan Kettering Cancer Center, New York, NY 		Add
149 Successful External Validation of the Calculator for Ovarian Subtype Prediction in a Clinical Trial Case Series (1180)
S Kommoss, J Pfisterer, B Gilks, F Kommoss, M Kobel, C Chow, D Huntsman, SE Kalloger - University of British Columbia, Vancouver, BC, Canada; AGO Study Group, Wiesbaden, Germany; Vancouver General Hospital, Vancouver, BC, Canada; University of Calgary, Calgary, AB, Canada; British Columbia Cancer Agency, Vancouver, BC, Canada 		Add
150 Utility of the SNaPshot Assay in Ovarian Carcinoma Genotyping (1191)
J Loureiro, D Borger, K Van de Vijver, D Dias-Santagata, R Penson, J Iafrate, E Oliva - Massachusetts General Hospital, Boston, MA 		Add
151 Identification of an Effective Immunohistochemical Panel in Distinction of Breast Carcinoma from Ovarian Serous Carcinoma (1186)
F Lin, J Prichard, M Zhang, H Liu - Geisinger Medical Center, Danville, PA 		Add
152 Survey of Mammaglobin Expression by Immunohistochemistry in Gynecologic Carcinomas (1149)
IS Hagemann, JD Pfeifer, D Cao - Washington University School of Medicine, St. Louis, MO 		Add
153 DPEP1, a Useful Immunohistochemical Tool in Distinguishing Primary from Metastatic Endometrioid and Mucinous Ovarian Tumors (1200)
E Marchetti, A Kumarapeli, W Mojica - State University of New York at Buffalo, Buffalo, NY 		Add
154 Value of SATB2 in the Differential Diagnosis of Intestinal- Type Mucinous Tumors of the Ovary (1230)
D Perez Montiel, K Arispe Angulo, G Moncada, L Pena, L Bornstein, J Chanona, D Cantu de Leon - Instituto Nacional de Cancerologia, Mexico City, Mexico; InmunoQ, Mexico City, Mexico 		Add
155 Transitional Cell Tumors of Ovary: Immunohistochemical Profile with Reference to Markers for Transitional Cell Carcinoma (1242)
J Schwartz, M Amin - William Beaumont Hospital, Royal Oak, MI 		Add
156 Mutually Exclusive Expression of PAX8 and p63 in Transitional Cell Tumors of the Ovary (1154)
MR Hawver, J-J Wei, X-W Chen, D Hamele-Bena, J Wright, G-X Tong - Columbia University Medical Center, New York, NY; Northwestern University, Chicago, IL 		Add
157 Transitional Cell-Like Growth in Ovarian Endometrioid Carcinoma: Clinicopathological, Immunohistochemical and Behavioral Features Distinguishing It from High Grade Serous Carcinoma (1175)
AN Karnezis, A Aysal, CJ Zaloudek, JT Rabban - UCSF, San Francisco, CA 		Add
158 Small Cell Carcinoma Hypercalcemic Type: Consistent Clinico-Pathologic Features and Lack of Molecular Markers (1110)
E D´Angelo, C Rivera, B Canet, A Mozos, J Prat - Hospital de la Santa Creu i Sant Pau. Institute of Biomedical Research (IIB Sant Pau). Autonomous University of Barcelona, Barcelona, Spain 		Add
159 Association of Isolated Single Umbilical Artery with Maternal Health and Placental Pathology; a Retrospective Study of over 6,500 Placentas (1252)
A Treece, S Reilly, O Faye-Petersen - University of Alabama, Birmingham, Birmingham, AL 		Add
160 Diagnosis of Partial Hydatidiform Mole: Histological Reassessment in Correlation with DNA Genotyping (1098)
N Buza, P Hui - Yale University School of Medicine, New Haven, CT 		Add
161 Multiplex Short Tandem Repeat (STR) Genotyping of Complete Hydatidiform Moles: Analysis of Zygosity and Presence of Invasive Gestational Trophoblastic Disease at Presentation (1216)
N Nasseri-Nik, C DeScipio, KM Murphy, R Vang, BM Ronnett - The Johns Hopkins Medical institutions, Baltimore, MD 		Add
162 Choriocarcinoma at a First Trimester (1138)
M Fukunaga - Jikei University Daisan Hospital, Tokyo, Japan 		Add
163 Significance of Complement Split Product C4d Deposition in Paraffin-Embedded Placenta of Systemic Lupus Erythematosus (SLE) and Pregnancy Induced Hypertension (PIH) (1210)
S Minamiguchi, Y Mikami, Y Iemura, E Kondoh, K Tatsumi, I Konishi, H Haga - Kyoto University Hospital, Kyoto, Japan 		Add